Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding VanEck Vectors Biotech ETF is 'Hold'. Macroaxis provides VanEck Vectors Biotech ETF buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding VanEck Vectors positions. The advice algorithm takes into account all of VanEck Vectors Biotech ETF available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from VanEck Vectors buy-and-hold prospective. Check also VanEck Vectors Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
VanEck Vectors Current RecommendationFor the selected time horizon VanEck Vectors Biotech ETF has a risk adjusted performance of 0.14, jensen alpha of 0.13, total risk alpha of 0.12, sortino ratio of 0.0 and treynor ratio of 1.04Macroaxis provides recommendation on VanEck Vectors Biotech to complement and cross-verify current analyst consensus on VanEck Vectors Biotech ETF. Our buy or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. Please use VanEck Vectors Biotech One Year Return and Net Asset to make buy, hold, or sell decision on VanEck Vectors.
Returns Distribution Density
VanEck Vectors Greeks
VanEck Vectors Volatility Alert
|Better Than Average||Worse Than Average||Compare VanEck Vectors to competition|